Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(2.34)
# 1,521
Out of 4,496 analysts
163
Total ratings
43.66%
Success rate
-2.1%
Average return
Main Sectors:
Top Industries:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGEN Agenus | Downgrades: Neutral | $40 → $9 | $5.99 | +50.25% | 9 | Jul 18, 2024 | |
| PPBT Purple Biotech | Reiterates: Buy | $10 | $0.37 | +2,580.97% | 11 | Jul 11, 2024 | |
| CNTX Context Therapeutics | Reiterates: Buy | $5 | $2.12 | +135.85% | 8 | Jul 10, 2024 | |
| ATOS Atossa Therapeutics | Reiterates: Buy | $6 | $1.34 | +347.76% | 5 | Jun 28, 2024 | |
| NKTX Nkarta | Reiterates: Buy | $23 | $6.21 | +270.37% | 11 | Jun 27, 2024 | |
| FEMY Femasys | Reiterates: Buy | $13 | $1.09 | +1,092.66% | 9 | Jun 20, 2024 | |
| VTYX Ventyx Biosciences | Reiterates: Neutral | $6 | $2.55 | +135.29% | 10 | Jun 13, 2024 | |
| CNTB Connect Biopharma Holdings | Reiterates: Buy | $8 | $1.27 | +529.92% | 3 | Jun 13, 2024 | |
| OLMA Olema Pharmaceuticals | Reiterates: Buy | $30 | $14.31 | +109.64% | 11 | Jun 4, 2024 | |
| BCTX BriaCell Therapeutics | Reiterates: Buy | $18 | $0.79 | +2,178.48% | 7 | Jun 4, 2024 | |
| NVCR NovoCure | Reiterates: Neutral | $22 | $18.40 | +19.57% | 11 | Jun 4, 2024 | |
| NXTC NextCure | Reiterates: Buy | $8 | $1.69 | +373.37% | 5 | Jun 3, 2024 | |
| RNAZ TransCode Therapeutics | Reiterates: Buy | $3 | $0.83 | +261.88% | 8 | May 29, 2024 | |
| SLRN Acelyrin | Maintains: Buy | $16 → $18 | $6.51 | +176.50% | 9 | May 22, 2024 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $65 | $20.24 | +221.15% | 3 | May 20, 2024 | |
| IOBT IO Biotech | Maintains: Buy | $8 → $12 | $1.58 | +659.49% | 6 | May 15, 2024 | |
| ACRV Acrivon Therapeutics | Maintains: Buy | $20 → $22 | $7.33 | +200.14% | 7 | May 14, 2024 | |
| INKT MiNK Therapeutics | Reiterates: Buy | $9 | $0.88 | +922.73% | 7 | May 14, 2024 | |
| IMNN Imunon | Maintains: Buy | $13 → $12 | $1.25 | +860.00% | 6 | May 14, 2024 | |
| GNLX Genelux | Reiterates: Buy | $32 | $2.21 | +1,347.96% | 3 | May 13, 2024 | |
| ACLX Arcellx | Maintains: Buy | $82 → $80 | $62.56 | +27.88% | 9 | May 13, 2024 | |
| SANA Sana Biotechnology | Reiterates: Buy | $12 | $5.80 | +106.90% | 4 | May 9, 2024 | |
| LTRN Lantern Pharma | Reiterates: Neutral | n/a | $4.41 | - | 1 | Apr 25, 2024 |
Agenus
Jul 18, 2024
Downgrades: Neutral
Price Target: $40 → $9
Current: $5.99
Upside: +50.25%
Purple Biotech
Jul 11, 2024
Reiterates: Buy
Price Target: $10
Current: $0.37
Upside: +2,580.97%
Context Therapeutics
Jul 10, 2024
Reiterates: Buy
Price Target: $5
Current: $2.12
Upside: +135.85%
Atossa Therapeutics
Jun 28, 2024
Reiterates: Buy
Price Target: $6
Current: $1.34
Upside: +347.76%
Nkarta
Jun 27, 2024
Reiterates: Buy
Price Target: $23
Current: $6.21
Upside: +270.37%
Femasys
Jun 20, 2024
Reiterates: Buy
Price Target: $13
Current: $1.09
Upside: +1,092.66%
Ventyx Biosciences
Jun 13, 2024
Reiterates: Neutral
Price Target: $6
Current: $2.55
Upside: +135.29%
Connect Biopharma Holdings
Jun 13, 2024
Reiterates: Buy
Price Target: $8
Current: $1.27
Upside: +529.92%
Olema Pharmaceuticals
Jun 4, 2024
Reiterates: Buy
Price Target: $30
Current: $14.31
Upside: +109.64%
BriaCell Therapeutics
Jun 4, 2024
Reiterates: Buy
Price Target: $18
Current: $0.79
Upside: +2,178.48%
NovoCure
Jun 4, 2024
Reiterates: Neutral
Price Target: $22
Current: $18.40
Upside: +19.57%
NextCure
Jun 3, 2024
Reiterates: Buy
Price Target: $8
Current: $1.69
Upside: +373.37%
TransCode Therapeutics
May 29, 2024
Reiterates: Buy
Price Target: $3
Current: $0.83
Upside: +261.88%
Acelyrin
May 22, 2024
Maintains: Buy
Price Target: $16 → $18
Current: $6.51
Upside: +176.50%
Jasper Therapeutics
May 20, 2024
Reiterates: Buy
Price Target: $65
Current: $20.24
Upside: +221.15%
IO Biotech
May 15, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $1.58
Upside: +659.49%
Acrivon Therapeutics
May 14, 2024
Maintains: Buy
Price Target: $20 → $22
Current: $7.33
Upside: +200.14%
MiNK Therapeutics
May 14, 2024
Reiterates: Buy
Price Target: $9
Current: $0.88
Upside: +922.73%
Imunon
May 14, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $1.25
Upside: +860.00%
Genelux
May 13, 2024
Reiterates: Buy
Price Target: $32
Current: $2.21
Upside: +1,347.96%
Arcellx
May 13, 2024
Maintains: Buy
Price Target: $82 → $80
Current: $62.56
Upside: +27.88%
Sana Biotechnology
May 9, 2024
Reiterates: Buy
Price Target: $12
Current: $5.80
Upside: +106.90%
Lantern Pharma
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.41
Upside: -